'25e-'26e EBIT up 6-15% Return to organic growth likely in Q2'25 '25e-'26e EV/EBIT of 14x-6x Starti...
Weak market coupled with portfolio rebalancing headwinds We lower '25e-'26e EBIT by 4-3% Poised for ...
Binero IT has outlined ambitious financial goals, aiming for solid organic growth and improved profi...
Redeye saw a report with sales that were lower than our expectations.
Redeye provides an update following CLS’s Q4 2024 report.
Redeye updated its forecast and valuation following the Q4 report, in which results came in largely ...
Solid Q4, despite tough comps Strong orders (+52% y-o-y) and profitability improvements 14x-9x '25e-...
Q4 NAV beat our estimate... ...driven by valuation increases in private portfolio Fair value increas...
Absolent’s Q4 numbers are well in line with Redeye’s expectations on Group level in terms of sales a...
Björn Borg (” Björn Borg” or ”the Company”) published its Year-End report for 2024 on February 21, 2...
Administer is set to release its Q4 results on Wednesday, March 5th.
Sales -4% vs. ABGSCe (-11% y-o-y), EBIT -24% vs. ABGSCe Weaker orders but improving margins, partly ...
Today, 13.00-13.45, Clinical Laserthermia Systems CEO Dan Mogren and CFO Håkan Rosqvist will present...
Umida är en företags- och varumärkesgrupp som utvecklar, marknadsför och säljer drycker med och utan...
Sales SEK 53m and EBIT SEK -5m (vs. ABGSCe 49m & -4m) Changed reporting period, now follows calendar...
Sales SEK 432m +3% vs. ABGSCe 419m EBIT better than expected Consensus EBIT estimate revisions likel...
Redeye comments on Binero IT’s H2-24 results. Sales were SEK212m in the second half of the year, rep...
Redeye states that Safello’s Q4 2024 report aligned with its estimates on the most prominent items.
Redeye shares its initial comments on Modelon’s Q4 2024 results, where ARR slightly exceeded expecta...
Net sales and clean EBIT were close to market consensus (LSEG) in Q4.
